[Use of Bayer E 39 in otolaryngology; clinical and histological study].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004938:Esophageal Neoplasms; D007822:Laryngeal Neoplasms; D007830:Larynx; D008175:Lung Neoplasms / Q000628:therapy*; D010036:Otolaryngology; D014066:Palatine Tonsil; D011809:Quinones / Q000627:therapeutic use*; D014067:Tonsillar Neoplasms
D000970:Antineoplastic Agents; D011809:Quinones
CYTOTOXIC DRUGS/therapeutic use; ESOPHAGUS/neoplasms; LARYNX/neoplasms; LUNG NEOPLASMS/therapy; QUINONES/therapeutic use; TONSILS/neoplasms
Die Anwendung von Bayer E 39 in der Oto-Laryngologie; eine klinische und histologische Studie.